Response Genetics Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$54.31 K |
Shares Outstanding |
38.8 M |
Public Float |
- |
Address |
1640 Marengo Street Los Angeles California 90033 United States |
Employees | - |
Website | http://www.responsegenetics.com |
Updated | 07/08/2019 |
Response Genetics, Inc. engages in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. |